P
32.69
0.67 (2.09%)
AIStockmoo Score
-0.3
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.25 |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Wealth Enhancement Advisory Services, Llc | 30 Jun 2025 | 0 |
| Tradewinds Capital Management, Llc | 30 Jun 2025 | 0 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 16 Sep 2025 | Announcement | Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free |
| 08 Sep 2025 | Announcement | Pelthos Therapeutics to Participate in Upcoming September Investor Conferences |
| 02 Sep 2025 | Announcement | Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference |
| 18 Aug 2025 | Announcement | Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update |
| 10 Jul 2025 | Announcement | Pelthos Therapeutics Launches ZELSUVMI™ (berdazimer) Topical Gel 10.3%, the First and Only FDA-Approved At-Home Treatment for Molluscum Contagiosum |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |